Eaton (NYSE:ETN) resets as $13 billion loss hits targets

Eaton (NYSE:ETN) resets as $13 billion loss hits targets

NEW YORK, June 27, 2026, 14:03 EDT

  • Eaton is down 7.6% for the past five sessions, ending Friday at $402.68. Shares are now 7.8% under the June 22 high.
  • Friday saw 5.27 million shares traded, roughly 205% above the 65-day average volume.
  • No analysts have sell ratings on the stock, WSJ/FactSet data says. The average price target comes in at $468.95, which is around 16% higher than where the shares closed Friday.

U.S. equity markets did not open Saturday. The coming week is a short one for stocks, as Nasdaq’s 2026 calendar confirms markets are closed Friday, July 3, for the Independence Day observance. Normal trading runs Monday to Friday, 9:30 a.m. to 4 p.m. ET, according to nasdaq.com.

Eaton Corporation plc swung lower last week. Shares reached a 52-week high of $436.74 on Monday, before dropping to $402.68 by Friday’s close. With 387.9 million shares outstanding, that drop slashed roughly $13.2 billion from the company’s equity, according to MarketWatch.

Eaton saw a deeper slide than the broader market. The stock is down 7.6% over five days, while the S&P 500 Index (INDEXSP:.INX) lost 1.95%. On Friday, Eaton fell 4.09%. The S&P 500 dipped just 0.05%.

Heavy volume hit the stock Friday, with 5.27 million shares trading hands—more than twice the 65-day average. Shares edged up 1.26% to $407.75 after hours, though most funds will start Monday with the regular session close.

Eaton trades at a premium. At Friday’s close it was around 30 times the WSJ/FactSet 2026 EPS forecast of $13.34. That gives investors little cushion if questions rise over data-center demand or how long its acquisitions take to pay off.

Wall Street is still bullish. According to WSJ/FactSet, there were 18 buys, four overweight calls, five holds, and one underweight, with zero sell ratings. The mean price target came in at $468.95—around 16% higher than where shares finished on Friday.

Eaton pointed to the order book. On May 5, its first-quarter report showed Electrical Americas rolling average orders jumped 42% organically, fueled by data-center demand. Total electrical backlog climbed 48% year over year. Eaton reported first-quarter sales up 17% to $7.5 billion and bumped its 2026 organic growth outlook to 9%-11%.

Eaton CEO Paulo Ruiz said in a statement that “strong demand across our markets drove solid first quarter performance.” Business Wire

Eaton’s portfolio move is in the premium too. The company said this month it will merge its mobility business with Dana Incorporated . Reuters reported the deal would value Eaton’s unit at around $5.1 billion and give Eaton room to double down on its electrical and aerospace segments.

Bernstein’s Chad Dillard said, “The market still underestimates the earnings power of the ‘new’ Eaton,” pointing to Eaton after dropping mobility and making some new higher-growth deals. Reuters

Eaton’s next earnings report is set for Aug. 4, according to WSJ/FactSet.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.
SK hynix (KRX:000660) plunge erases value equal to four pending ADR offerings in a single session
Previous Story

SK hynix (KRX:000660) plunge erases value equal to four pending ADR offerings in a single session

AbbVie grabs Apogee in $10.9 billion deal as buyouts speed up
Next Story

AbbVie (NYSE:ABBV) jumps $18 billion Friday, beats Apogee as Skyrizi FDA decision comes Monday